Prevalence of TSH receptor and Gsα mutations in 45 autonomously functioning thyroid nodules in Japan

Endocrine Journal

Volumn 56, Issue 6, 2009, Pages 791-798

  Nishihara, Eijun ^a   Amino, Nobuyuki ^a   Maekawa, Kayoko ^a   Yoshida, Hiroshi ^a   Ito, Mitsuro ^a   Kubota, Sumihisa ^a   Fukata, Shuji ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Autonomously functioning thyroid nodule; Somatic mutation; Stimulatory G protein; Thyrotropin receptor

Indexed keywords

DNA; IODINE 131; LIOTHYRONINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CODON; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; HUMAN; HYPERTHYROIDISM; JAPAN; LIOTHYRONINE BLOOD LEVEL; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; THYROID ADENOMA; THYROID FUNCTION TEST; THYROID NODULE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; CODON; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IODINE; JAPAN; MALE; MIDDLE AGED; MUTATION; NUTRITIONAL STATUS; POLYMORPHISM, GENETIC; RECEPTORS, THYROTROPIN; SEQUENCE ANALYSIS, DNA; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NODULE; YOUNG ADULT;

EID: 70349961653     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K09E-073     Document Type: Article

References (38)

1. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G (1991) High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 229:415-420.
2. Baltisberger BL, Minder CE, Burgi H (1995) Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 132:546-549.
3. Nagata K, Takasu N, Akamine H, Ohshiro C, Komiya I, Murakami K, Suzawa A, Nomura T (1998) Urinary iodine and thyroid antibodies in Okinawa, Yamagata, Hyogo, and Nagano, Japan: the differences in iodine intake do not affect thyroid antibody positivity. Endocr J 45:797-803. (Pubitemid 29082604)
4. Nagataki S (2008) The average of dietary iodine intake due to the ingestion of seaweeds is 1.2 mg/day in Japan. Thyroid 18:667-668.
5. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F (1990) Two G protein oncogenes in human endocrine tumors. Science 249:655-659. (Pubitemid 20259082)
6. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651. (Pubitemid 23350535)
7. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G (1997) Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701. (Pubitemid 27337896)
8. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891. (Pubitemid 27509388)
9. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R (2001) Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691. (Pubitemid 32200314)
10. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R (2006) Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535-545. (Pubitemid 44608426)
11. Vassart G, Pardo L, Costagliola S (2004) A molecular dissection of the glycoprotein hormone receptors. Trends Biochem Sci 29:119-126. (Pubitemid 38314857)
12. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR (1991) Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349.
13. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S, Suarez HG (1995) Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351.
14. Du Villard JA, Schlumberger M, Wicker R, Caillou B, Rochefort P, Feunteun J, Monier R, Parmentier C, Suarez HG (1995) Role of ras and gsp oncogenes in human epithelial thyroid tumorigenesis. J Endocrinol Invest 18:124-126.
15. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agricola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuno A, Penin M, Victoria B (2008) Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 159:623-631.
16. Takeshita A, Nagayama Y, Yokoyama N, Ishikawa N, Ito K, Yamashita T, Obara T, Murakami Y, Kuma K, Takamatsu J, Ohsawa N, Nagataki S (1995) Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. J Clin Endocrinol Metab 80:2607-2611.
17. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van Sande J, Noguchi S (2002) Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291.
18. Tanaka K, Nagayama Y, Takeshita A, Namba H, Yamashita S, Niwa M, Nagataki S (1996) Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan. Thyroid 6:195-199. (Pubitemid 26279411)
19. Nishihara E, Fukata S, Hishinuma A, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A (2006) Sporadic Congenital Hyperthyroidism due to a Germline Mutation in the Thyrotropin Receptor Gene (Leu 512 Gln) in a Japanese Patient. Endocr J 53:735-740 (Pubitemid 46045117)
20. Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K, Miyauchi A (2007) A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism. Endocr J 54:927-934. (Pubitemid 351346775)
21. Kamiya Y, Murakami M, Yanagita Y, Koitabashi H, Nagamachi Y, Hosoi Y, Ogiwara T, Mizuma H, Iriuchijima T, Mori M (1998) Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas. Mol Cell Endocrinol 138:137-142. (Pubitemid 28302024)
22. Kosugi S, Hai N, Okamoto H, Sugawa H, Mori T (2000) A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. Eur J Endocrinol 143:471-477. (Pubitemid 30801904)
23. Georgopoulos NA, Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG (2003) Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287-292. (Pubitemid 37304698)
24. Greer CE, Lund JK, Manos MM (1991) PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies. PCR Methods Appl 1:46-50.
25. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM (1993) The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16:325-332. (Pubitemid 23170885)
26. Lin Z, Shenker A, Pearlstein R (1997) A model of the lutropin/ choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. Protein Eng 10:501-510. (Pubitemid 27246314)
27. Watson SG, Radford AD, Kipar A, Ibarrola P, Blackwood L (2005) Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism. J Endocrinol 186:523-537. (Pubitemid 41404071)
28. Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke R, Wynford-Thomas D, Eggo M, Ludgate M (2003) Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 144:4018-4030. (Pubitemid 37088757)
29. Fuhrer D, Lachmund P, Nebel IT, Paschke R (2003) The thyrotropin receptor mutation database: update 2003. Thyroid 13:1123-1126. (Pubitemid 38032396)
30. Kleinau G, Jaschke H, Neumann S, Lattig J, Paschke R, Krause G (2004) Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J Biol Chem 279:51590-51600. (Pubitemid 40017910)
31. Mueller S, Kleinau G, Jaeschke H, Neumann S, Krause G, Paschke R (2006) Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor. J Biol Chem 281:31638-31646. (Pubitemid 46041428)
32. Muhlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ, Heufelder AE (2000) Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European caucasian population. J Clin Endocrinol Metab 85:2640-2643. (Pubitemid 32269129)
33. Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve TS, Wilmshurst E, Wiseman J (1992) Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 75:886-889.
34. Cakir M, Arici C, Alakus H, Altunbas H, Balci MK, Karayalcin U (2007) Incidental thyroid carcinoma in thyrotoxic patients treated by surgery. Horm Res 67:96-99. (Pubitemid 46333778)
35. Ohayon R, Boeynaems JM, Braekman JC, Van den Bergen H, Gorin Y, Virion A (1994) Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system. Mol Cell Endocrinol 99:133-141. (Pubitemid 24048416)
36. 2 generation is inhibited by iodide in human thyroids. J Clin Endocrinol Metab 86:4339-4343.
37. Krohn K, Maier J, Paschke R (2007) Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumors. Nat Clin Pract Endocrinol Metab 3:713-720.
38. Al-Khafaji F, Wiltshire M, Fuhrer D, Mazziotti G, Lewis MD, Smith PJ, Ludgate M (2005) Biological activity of activating thyrotrophin receptor mutants: modulation by iodide. J Mol Endocrinol 34:209-220. (Pubitemid 40305561)